TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2017. The put-call ratio across all filers is 6.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,127,000 | -63.1% | 18,877 | -63.3% | 0.01% | -66.7% |
| Q2 2017 | $5,762,000 | -11.4% | 51,420 | -7.8% | 0.04% | -23.4% |
| Q1 2017 | $6,507,000 | +13.5% | 55,799 | +2.4% | 0.05% | +4.4% |
| Q4 2016 | $5,735,000 | +2.2% | 54,478 | +7.2% | 0.04% | -4.3% |
| Q3 2016 | $5,614,000 | -24.1% | 50,800 | 0.0% | 0.05% | -25.4% |
| Q2 2016 | $7,396,000 | +1816.1% | 50,800 | +1932.0% | 0.06% | +1475.0% |
| Q4 2015 | $386,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |